OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $168,223 | -74.9% | 53,574 | -58.8% | 0.00% | – |
Q2 2023 | $670,547 | +9863.6% | 129,951 | +10076.3% | 0.00% | – |
Q1 2023 | $6,730 | +87.6% | 1,277 | 0.0% | 0.00% | – |
Q4 2022 | $3,588 | -10.3% | 1,277 | +27.7% | 0.00% | – |
Q3 2022 | $4,000 | -99.7% | 1,000 | -99.7% | 0.00% | -100.0% |
Q2 2022 | $1,376,000 | +695.4% | 342,228 | +881.0% | 0.00% | – |
Q1 2022 | $173,000 | -73.8% | 34,884 | -63.2% | 0.00% | – |
Q4 2021 | $661,000 | -79.8% | 94,890 | -70.9% | 0.00% | -100.0% |
Q3 2021 | $3,266,000 | -60.6% | 326,628 | -44.1% | 0.00% | -66.7% |
Q2 2021 | $8,293,000 | -8.3% | 584,793 | +6.2% | 0.00% | 0.0% |
Q1 2021 | $9,039,000 | -29.6% | 550,864 | -11.2% | 0.00% | -25.0% |
Q4 2020 | $12,836,000 | +1133.0% | 620,096 | +353.5% | 0.00% | – |
Q3 2020 | $1,041,000 | -24.1% | 136,749 | -16.9% | 0.00% | -100.0% |
Q2 2020 | $1,371,000 | +741.1% | 164,596 | +400.4% | 0.00% | – |
Q1 2020 | $163,000 | -21.6% | 32,890 | -37.6% | 0.00% | – |
Q4 2019 | $208,000 | +163.3% | 52,695 | +103.6% | 0.00% | – |
Q3 2019 | $79,000 | +3850.0% | 25,883 | +5076.6% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | -75.0% | 500 | -74.0% | 0.00% | – |
Q4 2018 | $8,000 | -92.5% | 1,923 | -87.6% | 0.00% | – |
Q3 2018 | $107,000 | -49.3% | 15,536 | -50.3% | 0.00% | – |
Q2 2018 | $211,000 | +330.6% | 31,270 | +316.9% | 0.00% | – |
Q1 2018 | $49,000 | +88.5% | 7,500 | +26.2% | 0.00% | – |
Q4 2017 | $26,000 | -49.0% | 5,942 | -27.4% | 0.00% | – |
Q3 2017 | $51,000 | +6.2% | 8,185 | +58.9% | 0.00% | – |
Q2 2017 | $48,000 | -31.4% | 5,150 | -31.8% | 0.00% | – |
Q1 2017 | $70,000 | +150.0% | 7,556 | +128.1% | 0.00% | – |
Q4 2016 | $28,000 | -31.7% | 3,313 | -44.5% | 0.00% | – |
Q3 2016 | $41,000 | +115.8% | 5,973 | +54.7% | 0.00% | – |
Q2 2016 | $19,000 | +35.7% | 3,862 | +157.5% | 0.00% | – |
Q1 2016 | $14,000 | -75.4% | 1,500 | -75.4% | 0.00% | – |
Q4 2015 | $57,000 | +9.6% | 6,088 | +64.5% | 0.00% | – |
Q3 2015 | $52,000 | +1200.0% | 3,700 | +2014.3% | 0.00% | – |
Q2 2015 | $4,000 | -87.9% | 175 | -77.5% | 0.00% | – |
Q1 2015 | $33,000 | +153.8% | 778 | +38.4% | 0.00% | – |
Q4 2014 | $13,000 | – | 562 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
Covestor Ltd | 60,008 | $316 | 0.28% |
Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |